International patent applications for non-injectable naloxone for opioid overdose reversal: Exploratory search and retrieve analysis of the PatentScope database-Reference-Cited by-同舟云学术

International patent applications for non-injectable naloxone for opioid overdose reversal: Exploratory search and retrieve analysis of the PatentScope database

Published:2017-06-08 Issue:2 Volume:37 Page:205-215
ISSN:0959-5236
Container-title:Drug and Alcohol Review
language:en
Short-container-title:Drug and Alcohol Review

Author:

McDonald Rebecca¹^ORCID,Danielsson Glende Øyvind²³,Dale Ola²⁴,Strang John¹⁵

Affiliation:

1. National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience; King's College London; London UK

2. Department of Circulation and Medical Imaging; NTNU-The Norwegian University of Science and Technology; Trondheim Norway

3. Apotek 1 Nardo; Trondheim Norway

4. St. Olav's Hospital; University Hospital of Trondheim; Trondheim Norway

5. South London and Maudsley NHS Foundation Trust; London UK

Publisher

Wiley

Subject

Health (social science),Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dar.12571/fullpdf

Reference40 articles.

1. FDA FDA moves quickly to approve easy-to-use nasal spray to treat opioid overdose 2015 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm473505.htm

2. CBCnews Health Canada OK's non-prescription nasal spray overdose antidote 2016 http://www.cbc.ca/news/health/naloxone-nasal-spray-1.3789643

3. Increases in drug and opioid overdose deaths - United States, 2000-2014;CDC;MMWR Morb Mortal Wkly Rep,2016

4. WHO Information sheet on opioid overdose 2014 http://www.who.int/substance_abuse/information-sheet/en/

5. Expanded access to opioid overdose intervention: research, practice, and policy needs;Compton;Ann Intern Med,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetics of buprenorphine and naloxone sublingual combination in Chinese healthy volunteers and patients with opioid use disorder: Model-based dose optimization;Frontiers in Pharmacology;2023-01-19

2. Pharmacokinetic considerations for community-based dosing of nasal naloxone in opioid overdose in adults;Expert Opinion on Drug Metabolism & Toxicology;2022-03-04

3. Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review;BMC Public Health;2021-03-26

4. NTNU intranasal naloxone trial (NINA-1) study protocol for a double-blind, double-dummy, non-inferiority randomised controlled trial comparing intranasal 1.4 mg to intramuscular 0.8 mg naloxone for prehospital use;BMJ Open;2020-11

5. Factors associated with withdrawal symptoms and anger among people resuscitated from an opioid overdose by take-home naloxone: Exploratory mixed methods analysis;Journal of Substance Abuse Treatment;2020-10